multiple%20myeloma
MULTIPLE MYELOMA

Multiple myeloma is a bone marrow disease characterized by the presence of malignant plasma cells, & abnormal serum &/or urine immunoglobulin secondary to clonal plasma cell expansion.

It accounts for 1-2% of all cancers worldwide & mostly affects patients at ages 65-74 years old.

Patient usually presents with bone pain & nonspecific symptoms, or due to abnormalities in laboratory exams.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 29 May 2019

AstraZeneca has announced plans to invest over US$125 million (RM500 million) in Malaysia over the next 5 years, with a focus on patient-centred innovation, local talent development and new robotic and cognitive technologies.

Tristan Manalac, 29 May 2019
Beta blockers (BB) and renin-angiotensin inhibitors (RAI) effectively protect against anthracycline-induced cardiotoxicity among cancer patients, preserving left ventricular ejection fraction (LVEF) and cutting cardiac events, according to a new study presented at the recently concluded 2019 Congress of the Asian Pacific Society of Cardiology (APSC).